Sexually Transmitted Diseases

>

Latest News

FDA accepts priority review for gepotidacin as oral treatment for gonorrhea | Image credit Contemporary Pediatrics
FDA accepts priority review for gepotidacin as oral treatment for gonorrhea

August 12th 2025

FDA accepts priority review of gepotidacin, a first-in-class oral antibiotic, for treating uncomplicated urogenital gonorrhea in patients ≥12 years.

FDA approves lenacapavir as PrEP for HIV in adults, adolescents weighing at least 35 kg | Image Credit: Contemporary Pediatrics
FDA approves twice-yearly lenacapavir as PrEP for HIV in adolescents, adults

June 18th 2025

USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit | Image Credit: © Kostia - © Kostia - stock.adobe.com.
USPSTF: Syphilis screening during pregnancy has 'substantial' net benefit

May 14th 2025

Full recap from the 2025 Pediatric Academic Societies meeting |  Image Credit: © SCStock - © SCStock - stock.adobe.com.
Full recap from the 2025 Pediatric Academic Societies meeting

May 1st 2025

Lea Widdice, MD, director, Adolescent Medicine Fellowship; associate professor, University of Cincinnati Department of Pediatrics, Cincinnati, Ohio.
Uncovering the pediatrician's role in OTC STI testing, with Lea Widdice, MD

April 30th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.